KR20140146181A - 특정 치환체 분포를 갖는 에스테르화된 셀룰로즈 에테르 - Google Patents

특정 치환체 분포를 갖는 에스테르화된 셀룰로즈 에테르 Download PDF

Info

Publication number
KR20140146181A
KR20140146181A KR1020147031594A KR20147031594A KR20140146181A KR 20140146181 A KR20140146181 A KR 20140146181A KR 1020147031594 A KR1020147031594 A KR 1020147031594A KR 20147031594 A KR20147031594 A KR 20147031594A KR 20140146181 A KR20140146181 A KR 20140146181A
Authority
KR
South Korea
Prior art keywords
group
cellulose ether
esterified cellulose
hydroxyalkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020147031594A
Other languages
English (en)
Korean (ko)
Inventor
로베르트 엘. 슈미트
로베르트 엘. 샘러
마이놀프 브락하겐
올리버 페터만
롤란트 아덴
니콜라스 에스. 그라스만
스티븐 제이. 기요되
Original Assignee
다우 글로벌 테크놀로지스 엘엘씨
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47146713&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR20140146181(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 다우 글로벌 테크놀로지스 엘엘씨 filed Critical 다우 글로벌 테크놀로지스 엘엘씨
Publication of KR20140146181A publication Critical patent/KR20140146181A/ko
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4166—1,3-Diazoles having oxo groups directly attached to the heterocyclic ring, e.g. phenytoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B11/00—Preparation of cellulose ethers
    • C08B11/193—Mixed ethers, i.e. ethers with two or more different etherifying groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B13/00—Preparation of cellulose ether-esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicinal Preparation (AREA)
KR1020147031594A 2012-04-11 2012-10-24 특정 치환체 분포를 갖는 에스테르화된 셀룰로즈 에테르 Ceased KR20140146181A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261622754P 2012-04-11 2012-04-11
US61/622,754 2012-04-11
PCT/US2012/061586 WO2013154607A1 (en) 2012-04-11 2012-10-24 Esterified cellulose ethers having a specific substituent distribution

Publications (1)

Publication Number Publication Date
KR20140146181A true KR20140146181A (ko) 2014-12-24

Family

ID=47146713

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020147031594A Ceased KR20140146181A (ko) 2012-04-11 2012-10-24 특정 치환체 분포를 갖는 에스테르화된 셀룰로즈 에테르

Country Status (6)

Country Link
US (1) US9320799B2 (cg-RX-API-DMAC10.html)
EP (1) EP2836205B1 (cg-RX-API-DMAC10.html)
JP (1) JP6133969B2 (cg-RX-API-DMAC10.html)
KR (1) KR20140146181A (cg-RX-API-DMAC10.html)
CN (1) CN104427979B (cg-RX-API-DMAC10.html)
WO (1) WO2013154607A1 (cg-RX-API-DMAC10.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240046783A (ko) * 2021-08-26 2024-04-09 뉴트리션 ＆ 바이오사이언시즈 유에스에이 1, 엘엘씨 신규 하이드록시알킬 메틸셀룰로스 및 이의 용도

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6456849B2 (ja) 2013-03-01 2019-01-23 ハーキュリーズ・インコーポレーテッドＨｅｒｃｕｌｅｓ Ｉｎｃｏｒｐｏｒａｔｅｄ 高められた性能及び改善された加工性を有する医薬組成物
CN105025887B (zh) * 2013-03-07 2017-07-28 陶氏环球技术有限责任公司 新颖极低粘度酯化纤维素醚
JP6334574B2 (ja) * 2013-03-07 2018-05-30 ダウ グローバル テクノロジーズ エルエルシー 新規の超高分子量のエステル化セルロースエーテル
EP2997046B1 (en) * 2013-05-14 2019-09-25 Dow Global Technologies LLC Cellulose ethers esterified with dicarboxylic acids
KR102286952B1 (ko) * 2013-12-31 2021-08-09 롯데정밀화학 주식회사 입도분포가 조절된 히드록시프로필 메틸셀룰로오스 아세테이트 숙시네이트(hpmcas) 입자의 제조방법 및 hpmcas 분말
WO2015126576A1 (en) * 2014-02-20 2015-08-27 Dow Global Technologies Llc Novel esterified cellulose ethers of high molecular weight and homogeneity
WO2015179072A1 (en) * 2014-05-20 2015-11-26 Dow Global Technologies Llc Dispersion comprising a partially neutralized esterified cellulose ether
EP3186285B1 (en) 2014-08-27 2022-04-13 Nutrition & Biosciences USA 1, LLC Esterified cellulose ethers of low acetone-insoluble content
JP6203702B2 (ja) * 2014-11-18 2017-09-27 信越化学工業株式会社 ヒプロメロース酢酸エステルコハク酸エステルを用いたスプレードライ用溶液及び固体分散体の製造方法
JP6356923B2 (ja) * 2015-03-16 2018-07-11 ダウ グローバル テクノロジーズ エルエルシー 水溶性エステル化セルロースエーテル
MX2017011095A (es) 2015-03-16 2017-11-10 Dow Global Technologies Llc Eteres de celulosa esterificados solubles en agua que tienen grado bajo de neutralizacion.
MX2017011128A (es) * 2015-03-16 2017-11-28 Dow Global Technologies Llc Eteres de celulosa esterificada de gelificacion.
BR112017018146A2 (pt) * 2015-03-16 2018-04-10 Dow Global Technologies Llc processo para a preparação de um éter de celulose esterificado na presença de um ácido carboxílico alifático
WO2016148970A1 (en) * 2015-03-16 2016-09-22 Dow Global Technologies Llc Aqueous solution of an esterified cellulose ether
CN107567462B (zh) * 2015-05-15 2020-10-16 陶氏环球技术有限责任公司 用于制造具有极高分子量和低粘度的酯化纤维素醚的方法
US20180134811A1 (en) * 2015-06-05 2018-05-17 Dow Global Technologies Llc Cellulose ether powders
WO2016196152A1 (en) * 2015-06-05 2016-12-08 Dow Global Technologies Llc Cellulose ether powders
US20180273646A1 (en) * 2015-09-24 2018-09-27 Dow Global Technologies Llc. Process for preparing an ester of a cellulose ether in the presence of acetic acid and a reaction catalyst
BR112018005463A2 (pt) * 2015-10-02 2018-10-09 Dow Global Technologies Llc composição aquosa compreendendo éter de celulose esterificado disperso
US9884922B2 (en) * 2016-03-11 2018-02-06 Shin-Etsu Chemical Co., Ltd. Hypromellose acetate succinate, method for producing the same and composition containing the same
GB201609222D0 (en) 2016-05-25 2016-07-06 F2G Ltd Pharmaceutical formulation
WO2018170060A1 (en) * 2017-03-17 2018-09-20 Dow Global Technologies Llc Process for recovering an esterified cellulose ether from a reaction product mixture
MX2019013469A (es) * 2017-08-16 2020-02-07 Dow Global Technologies Llc Metodo para la preparacion controlada de eter de celulosa de bajo peso molecular.
JP7526727B2 (ja) * 2018-12-18 2024-08-01 ニュートリション アンド バイオサイエンシズ ユーエスエー １，リミティド ライアビリティ カンパニー ヒドロキシアルキルメチルセルロースを含む徐放性組成物
US11819503B2 (en) 2019-04-23 2023-11-21 F2G Ltd Method of treating coccidioides infection
JP7128782B2 (ja) 2019-08-09 2022-08-31 信越化学工業株式会社 エアゾール食品用組成物、ヒドロキシプロピルメチルセルロース及びヒドロキシプロピルメチルセルロースの製造方法
CN112704671B (zh) * 2020-12-28 2022-04-19 普洛药业股份有限公司 一种阿莫西林克拉维酸钾胶囊及其制备方法
WO2023023424A1 (en) 2021-08-19 2023-02-23 Phenom Pharmaceuticals, Inc. Compositions and methods for treatment of sars cov-2
CN114805787B (zh) * 2022-02-24 2023-09-12 南京林业大学 一种纤维素基聚醚多元醇脂肪酸酯增塑剂及其制备方法和应用
CN117659214A (zh) * 2023-10-16 2024-03-08 武汉理工大学 一种羟丙甲基纤维素的制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3435027A (en) 1965-12-13 1969-03-25 Hercules Inc Cellulose ether-esters and process
US4226981A (en) 1977-09-28 1980-10-07 Shin-Etsu Chemical Co., Ltd. Ether-ester derivatives of cellulose and their applications
DE2917104A1 (de) 1979-04-27 1980-11-06 Hoechst Ag Verfahren zur viskositaetserniedrigung von celluloseethern durch ozon und seine verwendung
US4365060A (en) 1979-04-28 1982-12-21 Shin-Etsu Chemical Co. Ltd. Enterosoluble capsules
JPS6225101A (ja) 1985-07-24 1987-02-03 Shin Etsu Chem Co Ltd 低重合度セルロ−スエ−テルの製造方法
JPS6281402A (ja) 1985-10-07 1987-04-14 Shin Etsu Chem Co Ltd セルロ−スエ−テル酸性ジカルボン酸エステルの製造方法
JP2916238B2 (ja) * 1990-10-16 1999-07-05 旭化成工業株式会社 アルキルセルロースの製造方法
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
JP3002916B2 (ja) * 1991-10-29 2000-01-24 ダイセル化学工業株式会社 セルロース混合エーテルの製造法
JP2872951B2 (ja) * 1995-11-07 1999-03-24 第一工業製薬株式会社 カルボキシメチルセルロースナトリウム塩
JP3996653B2 (ja) * 1996-01-26 2007-10-24 信越化学工業株式会社 置換度分布が制御されたヒドロキシプロピルセルロース
US6261218B1 (en) 1998-12-01 2001-07-17 The Dow Chemical Company Process and apparatus for making low molecular weight cellulose ethers
DE10141680B4 (de) 2001-08-25 2004-02-26 Clariant Gmbh Verfahren zur Herstellung niederviskoser Celluloseether durch sauer-oxidativen Abbau von gemahlenen und getrockneten Celluloseethern
EP1753402B1 (en) 2004-05-28 2008-10-01 Pfizer Products Incorporated Pharmaceutical compositions with enhanced performance comprising a hpmca polymer
JP2011074113A (ja) * 2009-09-29 2011-04-14 Toray Ind Inc セルロース混合エステルおよびその製造方法
WO2011159626A1 (en) * 2010-06-14 2011-12-22 Bend Research, Inc. Hydroxypropyl methyl cellulose acetate succinate with enhanced acetate and succinate substitution
CN105517537B (zh) 2013-09-25 2018-04-17 陶氏环球技术有限责任公司 包含纤维素醚的施加到粘膜的组合物

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240046783A (ko) * 2021-08-26 2024-04-09 뉴트리션 ＆ 바이오사이언시즈 유에스에이 1, 엘엘씨 신규 하이드록시알킬 메틸셀룰로스 및 이의 용도

Also Published As

Publication number Publication date
CN104427979A (zh) 2015-03-18
JP2015521209A (ja) 2015-07-27
EP2836205B1 (en) 2016-10-19
JP6133969B2 (ja) 2017-05-24
CN104427979B (zh) 2018-02-16
US20150065547A1 (en) 2015-03-05
US9320799B2 (en) 2016-04-26
WO2013154607A1 (en) 2013-10-17
EP2836205A1 (en) 2015-02-18

Similar Documents

Publication Publication Date Title
JP6133969B2 (ja) 特定の置換基分布を有するエステル化セルロースエーテル
CN105899542B (zh) 新颖低粘度酯化纤维素醚
JP6185559B2 (ja) 有機希釈剤およびセルロースエーテルを含む組成物
CN105007903B (zh) 具有极高分子量的酯化纤维素醚
CN105026435B (zh) 具有低粘度和高分子量的新颖酯化纤维素醚
CN105025887B (zh) 新颖极低粘度酯化纤维素醚
US20200188312A1 (en) Composition comprising an organic liquid diluent and a specific hydroxyalkyl methylcellulose
CN106661130A (zh) 不溶于丙酮的含量低的酯化纤维素醚
KR20180008523A (ko) 고분자량의 에스테르화된 셀룰로오스 에테르의 제조 방법
KR20180008524A (ko) 초고분자량 및 저점도의 에스테르화된 셀룰로오스 에테르의 제조 방법

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20141110

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20171011

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20180913

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20190128

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20180913

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I